Peter Staats

electroCore to Announce Second Quarter 2021 Financial Results on Thursday, August 5th

Retrieved on: 
Thursday, July 22, 2021
Medicine, Clinical medicine, Branches of biology, Headaches, Pain management, Migraine, Cluster headache, ElectroCore, Vagus nerve stimulation, Headache, Peter Staats, Migraine treatment

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology.

Key Points: 
  • electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology.
  • The company's current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.

electroCore announces Dr. Peter Staats to receive Lifetime Achievement Award from the American Society of Pain and Neuroscience

Retrieved on: 
Monday, July 19, 2021
Branches of biology, Nervous system, Medicine, Acute pain, Peter Staats, Pain management, Neurotechnology, North American Neuromodulation Society, American Society of Interventional Pain Physicians, Neuromodulation, Pain Physician, Pain

ROCKAWAY, NJ, July 19, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the Company), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its cofounder and Chief Medical Officer, Dr. Peter Staats, is to receive a Lifetime Achievement Award at the American Society of Pain and Neuroscience Annual Conference on July 24th, 2021.

Key Points: 
  • ROCKAWAY, NJ, July 19, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the Company), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its cofounder and Chief Medical Officer, Dr. Peter Staats, is to receive a Lifetime Achievement Award at the American Society of Pain and Neuroscience Annual Conference on July 24th, 2021.
  • Dr. Staats will be honored for his lifelong contribution to field of pain and neuromodulation, advancing the relief from pain through science, clinical education, and research.
  • Dr. Staats has written or co-edited 13 books and over 450 articles, abstracts, monographs, and book chapters on pain medicine in publications that include the Journal of the American Medicine Association, Pain, Anesthesiology, Lancet Neurology and the Journal of Clinical Oncology.
  • Dr. Staats is the former President of the North American Neuromodulation Society, American Society of Interventional Pain Physicians, New Jersey Society of Interventional Pain Physicians, and the Southern Pain Society.

Independence from Pain: World Institute of Pain Spotlights Advancements Helping Free Patients from Chronic Pain

Retrieved on: 
Thursday, July 1, 2021
Mental health, Health, Other Health, Research, Science, Pharmaceutical, Biotechnology, Pain, Branches of biology, Medicine, Pain management, Nociception, Headaches, Acute pain, Fibromyalgia, Chronic pain, Migraine, Chronic condition, Peter Staats

On this Independence Day, the World Institute of Pain highlights the growing field of research and treatment options which are helping Americans live free from chronic pain.

Key Points: 
  • On this Independence Day, the World Institute of Pain highlights the growing field of research and treatment options which are helping Americans live free from chronic pain.
  • Dr. Peter Staats, President of the World Institute of Pain, says, Chronic pain has historically been viewed through a behavioral lens as though it were purely in patients heads.
  • While patients understand that chronic pain is not imaginary, physicians can also do their part to free patients from the stigma associated with it by employing a holistic approach that considers three modulators of chronic pain: cognition, behavior and biology.
  • There are many types of chronic pain, such as migraine and cluster headaches, chronic back pain, cancer pain, fibromyalgia, and most recently, COVID-19 long-haul symptoms.

Nura Clinic Founder, David Schultz, MD, Honored with Lifetime Achievement Award

Retrieved on: 
Thursday, July 1, 2021
Pain management, American Society of Interventional Pain Physicians, Paducah, Kentucky, Medical specialties, Medicine, Clinical medicine, Laxmaiah Manchikanti, Interventional pain management, Nura, Pain Physician, Peter Staats

MINNEAPOLIS, July 1, 2021 /PRNewswire-PRWeb/ -- Nura Pain Clinic founder and Chief Executive Officer, David M. Schultz, MD was honored with the American Society of Interventional Pain Physicians (ASIPP) Lifetime Achievement Award during the 2021 ASIPP Annual Meeting on June 25 at the Hilton New Orleans Riverside.

Key Points: 
  • MINNEAPOLIS, July 1, 2021 /PRNewswire-PRWeb/ -- Nura Pain Clinic founder and Chief Executive Officer, David M. Schultz, MD was honored with the American Society of Interventional Pain Physicians (ASIPP) Lifetime Achievement Award during the 2021 ASIPP Annual Meeting on June 25 at the Hilton New Orleans Riverside.
  • The ASIPP Lifetime Achievement award is given to recognize a leader in the field of Interventional Pain Management (IPM).
  • "The ASIPP Board of Directors unanimously voted for Dr. David Schultz for the 2021 Lifetime Achievement Award," said Dr. Laxmaiah Manchikanti, ASIPP Chairman and CEO.
  • In addition to founding Nura Pain Clinic (formerly MAPS Medical Pain Clinics) in 1995, he is the founder and principal investigator for the Nura Research Institute.

electroCore to Announce First Quarter 2021 Financial Results on Thursday, May 6

Retrieved on: 
Thursday, April 29, 2021
Medicine, Clinical medicine, Branches of biology, Headaches, Pain management, Migraine, Cluster headache, ElectroCore, Vagus nerve stimulation, Headache, Peter Staats, Migraine treatment

b"electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology.

Key Points: 
  • b"electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology.
  • The company's current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.\n"

electroCore to Announce Fourth Quarter and Year Ended December 31, 2020 Financial Results on Thursday, March 11

Retrieved on: 
Thursday, March 4, 2021
Branches of biology, Medicine, Clinical medicine, Headaches, Pain management, Cluster headache, Migraine, ElectroCore, Vagus nerve stimulation, Headache, Vagus nerve, Peter Staats

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology.

Key Points: 
  • electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology.
  • The companys current indications are the adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, and the acute and preventive treatment of migraine in adolescent (ages 12 and older) and adult patients.

Non-Invasive Vagus Nerve Stimulation (nVNS) Enters New Stage of COVID-19 Research

Retrieved on: 
Wednesday, February 24, 2021
Professional services, Health, Medical devices, Infectious diseases, Finance, General Health, Biotechnology, Branches of biology, Neuroscience, Neurophysiology, Neurotechnology, Autonomic nervous system, Neuromodulation, Neuropsychology, ElectroCore, Vagus nerve, Peter Staats, electroCore, Inc., gammaCore

Closing enrollment for this study is an important step to better understanding the clinical benefit of non-invasive vagus nerve stimulation (nVNS) and how it can help patients suffering from COVID-19 respiratory distress.

Key Points: 
  • Closing enrollment for this study is an important step to better understanding the clinical benefit of non-invasive vagus nerve stimulation (nVNS) and how it can help patients suffering from COVID-19 respiratory distress.
  • In fact, the most downloaded 2020 article in the Journal of Neuromodulation was The Use of Noninvasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated With COVID19: A Theoretical Hypothesis and Early Clinical Experience .
  • Research should be focused on identifying novel therapies with strong clinical rationale that can be used throughout the course of disease.
  • electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology.

Dr. Pankaj Mehta Appointed Chief Medical Officer of Central Texas Pain Center, Pain Specialists of Austin, and Pain Specialists of America

Retrieved on: 
Tuesday, February 2, 2021
Pain, Nervous system, Pain management, Acute pain, Nociception, Palliative care, Chronic pain, Interventional pain management, Medical specialty, American Society of Interventional Pain Physicians, Peter Staats

AUSTIN, Texas, Feb. 2, 2021 /PRNewswire/ --Pain Specialists of America, a management service organization providing administrative healthcare services to Central Texas Pain Center and Pain Specialists of Austin in the Central Texas interventional pain management market, is pleased to announce that Dr. Pankaj Mehta has been appointed Chief Medical Officer over all group clinical activities.

Key Points: 
  • AUSTIN, Texas, Feb. 2, 2021 /PRNewswire/ --Pain Specialists of America, a management service organization providing administrative healthcare services to Central Texas Pain Center and Pain Specialists of Austin in the Central Texas interventional pain management market, is pleased to announce that Dr. Pankaj Mehta has been appointed Chief Medical Officer over all group clinical activities.
  • Dr. Mehta has gained national recognition for his contributions to Interventional Pain Medicine.
  • Central Texas Pain Center and Pain Specialists of Austin are two leading interventional pain management group practices in Central Texas committed to treating patients suffering from all types of acute or chronic pain.
  • About Pain Specialists of America: Pain Specialists of America is a practice management company that provides management services to Central Texas Pain Center's and Pain Specialists of Austin's 17 interventional pain clinics and urine toxicology labs.

electroCore Announces Selection of gammaCore for National Institute on Drug Abuse (NIDA)-Sponsored Study in Opioid Use Disorders

Retrieved on: 
Tuesday, December 1, 2020
Pain, Branches of biology, Nervous system, Peter Staats, ElectroCore, Acute pain, Emory University, Addiction, Master of Business Administration

The study is being run by Dr. Douglas Bremner at Emory University in collaboration with the Georgia Institute of Technology and the City University of New York and is supported by the National Institute on Drug Abuse (NCT04556552).

Key Points: 
  • The study is being run by Dr. Douglas Bremner at Emory University in collaboration with the Georgia Institute of Technology and the City University of New York and is supported by the National Institute on Drug Abuse (NCT04556552).
  • The study will enroll 40 subjects, in two separate study groups of 20 subjects each.
  • Each study group will randomize 10 subjects to be treated with nVNS and 10 with sham stimulation.
  • Peter Staats, MD, MBA, Chief Medical Officer of electroCore and President-elect of the World Institute of Pain, stated: Addiction is a significant health crisis in the United States.

Harvard-trained Veteran Joins Physician Partners of America

Retrieved on: 
Tuesday, September 24, 2019
Pain management, Medicine, Interventional pain management, Clinical medicine, Health, American Society of Interventional Pain Physicians, Peter Staats

brings over 25 years of specialized clinical expertise in interventional pain management to the care of his patients.

Key Points: 
  • brings over 25 years of specialized clinical expertise in interventional pain management to the care of his patients.
  • Dr. Greaser earned a Bachelor of Arts degree in English from the University of Richmond, where he was a scholarship collegiate football player.
  • After teaching high school English and coaching football, he attended medical school at the University of Virginia School of Medicine where he graduated in 1990.
  • Over his medical career, he has traveled throughout Europe, Canada and the United States instructing physicians in advanced techniques in interventional pain management.